stockrow
Saturday 7 November 2026
Export HITI’s income statement to Excel — free account
High Tide Inc.
HITI Healthcare Pharmaceutical Retailers
High Tide Inc.’s revenue for fiscal 2025 (year ended October 2025) was $424.0 million, up 10.5% from fiscal 2024.
- Revenue
- +30.7%
- EPS
- +800.0%
- Free cash flow
- −7.91%
- Total debt
- +54.7%
Quarter to July 2026, against a year earlier
2.63
0.00
0.00%
Follow HITI
Alert me
| Oct '17 | Oct '18 | Oct '19 | Oct '20 | Oct '21 | Oct '22 | Oct '23 | Oct '24 | Oct '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 6 | 4 | 4 | 6 | 6 | 2 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.51 | 1.70 | 0.33 | 0.30 | 0.58 | 0.60 |
Altman Z-Score |
— | — | 12.29 | 6.36 | 1.90 | 0.22 | 1.20 | 2.94 | 1.52 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 4.40 | 0.00 | 0.00 | 9.97 | 11.47 | 26.38 |
Altman Z″-Score (non-manufacturers) |
— | 7.51 | (4.79) | (2.08) | 0.24 | (2.16) | (2.37) | (0.47) | (1.57) |
P/Operating CF |
(50.14) | (50.14) | (50.14) | 53.15 | 59.36 | 14.26 | 15.27 | 31.13 | 91.81 |
Beneish M-Score |
— | — | (4.21) | (2.39) | (1.49) | (3.23) | (3.77) | (3.72) | (3.01) |
P/B ratio |
79.07 | 79.07 | 79.07 | 4.08 | 2.03 | 0.73 | 1.09 | 2.10 | 3.48 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | 25 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 31.71 | 7.13 | 4.82 | 5.79 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.99 | 1.86 | 0.43 | 0.37 | 0.59 | 0.69 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 3.50 | 44.28 | 0.00 | 0.00 | 10.17 | 41.43 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 8.58 | (119.51) | 34.47 | 8.73 | 8.70 | 17.12 |
EV/FCF |
0.00 | 0.00 | 0.00 | 8.58 | (30.46) | (33.98) | 12.37 | 11.61 | 30.10 |
Quick Ratio |
0.32 | 3.52 | 0.30 | 0.38 | 0.54 | 0.56 | 0.65 | 0.83 | 0.54 |
Current Ratio |
0.50 | 6.76 | 1.18 | 0.70 | 1.13 | 1.07 | 1.18 | 1.40 | 1.37 |
Net Debt/EBITDA |
15.03 | 2.33 | (1.06) | 4.64 | 3.83 | (0.88) | (4.03) | 0.13 | 5.13 |
Debt/Assets |
0.00% | 0.09% | 50.16% | 61.35% | 17.91% | 22.66% | 27.93% | 21.05% | 28.22% |
Debt/Equity |
(1.93) | 0.00 | 2.17 | 3.65 | 0.29 | 0.38 | 0.49 | 0.36 | 0.96 |
Asset Turnover |
0.55 | 0.68 | 0.93 | 1.50 | 1.16 | 1.35 | 1.87 | 2.17 | 1.97 |
Operating CF/Net income |
3.51 | 1.94 | 0.56 | (1.39) | 0.08 | (0.06) | (0.53) | (8.20) | (0.47) |
Capex/Depreciation |
0.00 | 0.00 | (7.43) | (0.41) | (0.35) | (0.30) | (0.19) | (0.35) | (0.42) |
Interest Coverage |
0.00 | (48.73) | (6.43) | 0.08 | (1.22) | (6.97) | (4.26) | 0.50 | (1.12) |
| 4.45% | (66.85%) | (158.98%) | (59.84%) | (43.00%) | (45.18%) | (25.91%) | (3.09%) | (40.19%) | |
| 1.62% | (34.87%) | (78.43%) | (11.45%) | (22.49%) | (27.24%) | (15.08%) | (1.80%) | (16.85%) | |
ROIC |
0.00% | 0.00% | (42.85%) | 1.06% | (5.50%) | (22.71%) | (15.36%) | 2.09% | (5.89%) |
Return on Tangible Assets |
(2.91%) | (24.41%) | (183.59%) | (129.62%) | (115.80%) | (201.55%) | (104.41%) | (8.38%) | (76.42%) |
Average Days of Receivables |
179.34 | 38.28 | 27.82 | 12.54 | 14.46 | 8.39 | 5.67 | 2.31 | 3.45 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
35.84% | 42.06% | 73.50% | 24.13% | 28.29% | 24.09% | 19.04% | 18.01% | 17.73% |
Intangible Assets out of Total Assets |
0.00 | 0.04 | 0.30 | 0.26 | 0.58 | 0.53 | 0.44 | 0.38 | 0.37 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 7.06% | 0.15% | 2.69% | 2.26% | 1.03% | 0.57% | 0.66% |
Graham Net Nets |
(0.02) | (0.02) | (0.02) | (0.93) | (0.16) | (0.41) | (0.21) | (0.05) | (0.31) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(5.13%) | (5.13%) | (5.13%) | (7.07%) | (2.51%) | (60.96%) | (25.92%) | (1.15%) | (13.55%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 22.70% | (3.59%) | (3.86%) | 10.03% | 8.72% | 3.79% |
Revenue per Share |
0.62 | 0.53 | 0.12 | 0.27 | 3.39 | 4.42 | 4.86 | 4.82 | 5.16 |
Operating CF per Share |
0.06 | (0.53) | (0.06) | 0.03 | (0.05) | 0.06 | 0.21 | 0.33 | 0.21 |
Capex per Share |
0.00 | 0.00 | (0.04) | (0.01) | (0.15) | (0.11) | (0.06) | (0.08) | (0.09) |
Free Cash Flow per Share |
0.06 | (0.53) | (0.10) | 0.02 | (0.21) | (0.06) | 0.15 | 0.25 | 0.12 |
Cash per Share |
0.11 | 0.50 | 0.00 | 0.02 | 0.28 | 0.31 | 0.30 | 0.44 | 0.42 |
Shareholders Equity per Share |
(0.60) | 1.42 | 0.04 | 0.04 | 2.85 | 2.01 | 1.33 | 1.34 | 0.89 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.60) | 1.42 | 0.04 | 0.04 | 2.85 | 2.01 | 1.33 | 1.34 | 0.89 |
Free Cash Flow |
0.81 | (6.70) | (18.99) | 4.52 | (8.81) | (3.54) | 10.81 | 19.56 | 9.69 |
Working Capital |
(7.98) | 11.39 | 1.46 | (6.09) | 4.37 | 3.20 | 7.79 | 17.86 | 26.39 |
Capital Expenditures |
(0.04) | (3.23) | (7.83) | (2.06) | (6.57) | (7.03) | (4.51) | (6.55) | (7.35) |
Net Current Asset Value |
(8.00) | 11.38 | (13.99) | (28.87) | (38.11) | (37.79) | (23.05) | (10.95) | (78.09) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 61.80 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.33 | 0.03 | 0.05 | 0.03 | 0.01 | 0.02 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 61.03 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.28 | 0.02 | 0.11 | 0.52 | 0.95 | 0.96 | 1.21 | 0.92 | 0.83 |
Cash ROIC |
9.65% | (27.83%) | (82.21%) | 9.79% | (5.25%) | (1.83%) | 6.36% | 10.85% | 5.45% |
Accounts Receivable Turnover |
3.44 | 2.96 | 18.88 | 31.58 | 36.77 | 45.91 | 60.34 | 95.40 | 131.71 |
Accounts Payable Turnover |
6.09 | 9.77 | 7.26 | 9.65 | 9.55 | 11.16 | 14.52 | 16.92 | 12.28 |
Inventory Turnover |
1.53 | 2.45 | 3.90 | 8.39 | 10.47 | 12.53 | 14.11 | 13.67 | 9.03 |
Average Days of Payables |
46.39 | 45.82 | 80.43 | 44.68 | 57.74 | 38.35 | 21.41 | 22.88 | 39.16 |
Days of Inventory on Hand |
243.34 | 145.91 | 122.76 | 39.68 | 53.10 | 33.40 | 26.60 | 28.19 | 55.86 |
Average Receivables |
2.25 | 2.25 | 1.25 | 1.96 | 3.92 | 6.04 | 5.99 | 4.02 | 3.22 |
Average Payables |
0.68 | 0.68 | 2.07 | 4.04 | 9.76 | 17.81 | 18.19 | 16.49 | 25.61 |
Average Inventory |
2.69 | 2.69 | 3.85 | 4.65 | 8.90 | 15.87 | 18.72 | 20.41 | 34.84 |
Average Assets |
14.20 | 9.89 | 25.22 | 41.29 | 123.87 | 204.62 | 193.23 | 176.97 | 215.04 |
Average Common Equity |
5.16 | 5.16 | 12.44 | 7.90 | 64.80 | 123.38 | 112.48 | 103.00 | 90.14 |
Columns are period end dates · fundamentals updated 25 Oct 2026